ClinicalTrials.gg
CompletedNCT05264233CocoHeartUpdated Mar 3, 2022

The Acute Effects of Meals Rich in Saturated or Unsaturated Fatty Acids on Postprandial Lipaemia in Healthy Men

An interventional study of Coconut oil and Butter in Cardiovascular Risk Factor, sponsored by University of Reading. Completed at 1 site in United Kingdom. Open to male participants aged 30 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-03-03.

Sponsored by University of Reading · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 11 months after the study started (first participant enrolled Jan 2020, registered Dec 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
13
Allocation
Randomized
Ages
30 Years to 70 Years
Sex
Male
01

Study summary

Current dietary recommendations suggest that lowering intake of saturated fats or replacing it with unsaturated fats will decrease the risk of developing cardiovascular disease. Coconut oil has gained popularity in recent years but it contains 90% saturated fat, which has higher percentage of saturated fat than butter. To date, only limited studies have determined the acute effects of meals containing coconut oil on blood lipids, but findings are inconsistent. Therefore, further studies are needed to address this knowledge gap and compare the postprandial effects of test meals rich in coconut oil with other sources of saturated fatty acids such as butter and unsaturated fatty acids (vegetable oils). A cross-over, double-blind, randomised acute postprandial study will be conducted in 15 healthy men. Participants will be assigned to consume the test meals rich in saturated or unsaturated fatty acids in random order on 3 separate occasions, with 3-4 weeks between each study visit. Participants will be provided with breakfast (toast with jam and milkshake, 50g fat) and lunch (toast with jam and milkshake, 30g fat). The anthropometric, blood pressure, arterial stiffness, and breath samples will be taken for each study visit. Blood samples will be collected for the measurement of fasting lipids, glucose, insulin, inflammatory markers, whole blood culture as well as blood clotting. Breath samples are collected for the measurement of gastric emptying as well as assessment of satiety using questionnaires (100 mm visual analogue scale) completed throughout the day. The findings from this study will contribute to the evidence base on how consuming meals rich in coconut oil influence the level of blood lipids as well as other biomarkers for cardiovascular disease.

02

Conditions studied

  • Cardiovascular Risk Factor

Keywords

  • Coconut oil
  • Postprandial lipaemia
  • Platelet function
  • Gastric emptying
  • Appetite
03

In context

Lead sponsor

University of Reading is the lead sponsor of 150 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 70 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy men
  • Aged between 30 to 70 years
  • Serum triacylglycerol \< 2.3 mmol/l
  • Body mass index between 19-32 kg/m2
  • Total cholesterol \< 7.5 mmol/l

Exclusion criteria

Exclusion Criteria:

  • Females
  • Smokers
  • Medical history of myocardial infarction or stroke in the past 12 months
  • Diabetes (defined as fasting glucose > 7.0 mmol/l) or other endocrine disorders
  • Kidney, liver, pancreas or gastrointestinal disorder
  • Hypertension (blood pressure > 140/90 mmHg), cancer, medication for hyperlipidaemia (e.g. statins), hypertension or, inflammation
  • Anaemia (\<130 g/L haemoglobin)
  • Taking any dietary supplements known to influence lipids/gut microbiota (e.g. plant stanols, fish oil, phytochemicals, natural laxatives, probiotics and prebiotics)
  • Drinking in excess of 14 units of alcohol per week
  • Planning on a weight-reducing regime
  • Parallel participation in another dietary intervention study
  • Any other unusual medical history or diet and lifestyle habits or practices that would preclude volunteers from participating in a dietary intervention and metabolic study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
13 participants (actual)

Study arms

  • Active comparator
    Meal rich in coconut oil

    Participants will be asked to consume a breakfast (0 minute) and lunch (330 minute) rich in coconut oil

    Dietary Supplement: Coconut oil

  • Active comparator
    Meal rich in butter

    Participants will be asked to consume a breakfast (0 minute) and lunch (330 minute) rich in butter

    Dietary Supplement: Butter

  • Active comparator
    Meal rich in vegetable oil

    Participants will be asked to consume a breakfast (0 minute) and lunch (330 minute) rich in vegetable oil

    Dietary Supplement: Vegetable oil

Interventions

  • Dietary supplementCoconut oil

    50 g of coconut oil will be added to the test meal for breakfast and 30 g of coconut oil will be added to the test meal for lunch

  • Dietary supplementButter

    50 g of butter will be added to the test meal for breakfast and 30 g of butter will be added to the test meal for lunch

  • Dietary supplementVegetable oil

    50 g of vegetable oil will be added to the test meal for breakfast and 30 g of vegetable oil will be added to the test meal for lunch

06

What researchers measure

Primary outcomes

  1. Change from baseline in postprandial triacylglycerol

    Triacylglycerol

    Time frame: Acute study: taken at 0 (baseline), 30, 60, 90, 120, 180, 240, 300, 330, 360, 390, 420, 480 minutes

Secondary outcomes

  1. Fasting blood lipids

    Total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol

    Time frame: Acute study: taken at 0 (baseline)

  2. Change from baseline in postprandial non-esterified fatty acids

    Non-esterified fatty acids

    Time frame: Acute study: taken at 0 (baseline), 30, 60, 90, 120, 180, 240, 300, 330, 360, 390, 420, 480 minutes

  3. Change from baseline in postprandial insulin

    Insulin

    Time frame: Acute study: taken at 0 (baseline), 30, 60, 90, 120, 180, 240, 300, 330, 360, 390, 420, 480 minutes

  4. Change from baseline in postprandial vascular stiffness

    Measured via pulse wave assessment using the Mobil-O-graph device

    Time frame: Acute study: taken at 0 (baseline), 150, 315, 465 minutes

  5. Change from baseline in postprandial blood pressure

    Systolic and diastolic blood pressure

    Time frame: Acute study: taken at 0 (baseline), 180, 300, 480 minutes

  6. Change from baseline in postprandial thrombin generation

    Thrombin generation

    Time frame: Acute study: taken at 0 (baseline), 180, 330, 480 minutes

  7. Change from baseline in postprandial gastric emptying

    Assessed using gas chromatography-mass spectrometry

    Time frame: Acute study: taken at 15 minutes intervals between 0 min (baseline) and 480 minutes

  8. Appetite rating

    Assessed using 100 mm visual analogue questionnaire

    Time frame: Acute study: taken at 30 minutes intervals after the test meals up to 8 hours

  9. Change from baseline in postprandial gut hormones

    Ghrelin, peptide YY, gastric inhibitory polypeptide, glucagon-like peptide-1

    Time frame: Acute study: taken at 0 (baseline), 30, 60, 120, 240, 330, 360, 390 & 480 minutes

  10. Change from baseline in postprandial endothelial activation

    E-selectin, P-selectin, vascular cell adhesion molecule 1, intercellular adhesion molecule-1

    Time frame: Acute study: taken at 0 (baseline),180, 300 and 420 minutes

  11. Change from baseline in postprandial cytokine

    Interleukin 6, interleukin 1 beta, interleukin 10, tumour necrosis factor alpha, C-C motif chemokine ligand 5, C-X-C motif chemokine ligand 5

    Time frame: Acute study: taken at 0 (baseline),180, 300 and 420 minutes

  12. Weight

    Body mass index will be calculated (kg/ height in m\^2)

    Time frame: Acute study: taken at 0 (baseline)

  13. Body composition

    Fat mass, fat free mass, trunk fat, trunk fat mass, trunk fat free mass

    Time frame: Acute study: taken at 0 (baseline)

  14. Habitual diet assessment

    4-day food diary

    Time frame: Prior to the start of the study

Other outcomes

  1. Genotyping for apolipoprotein E

    Single nucleotide polymorphisms related to the metabolism of dietary fats

    Time frame: Acute study: taken at 0 (baseline)

07

Study locations

1 site
  • Department of Food and Nutritional Sciences, University of Reading
    Reading, Berkshire RG6 6AP, United Kingdom
08

References and documents

Publications

  • Wong G, Clegg ME, Ross D, Lovegrove JA, Jackson KG. Sequential Meals Containing Animal and Plant-Based Saturated Fats Have Differential Effects on Postprandial Gut Hormones but No Impact on Satiety Compared with Unsaturated Fats in Generally Healthy Males: Findings from the Randomized Controlled Crossover CocoHeart Study. J Nutr. 2025 Jul 1;155(9):3020-9. doi: 10.1016/j.tjnut.2025.06.027. Online ahead of print. PubMed 40609691 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 3, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05264233
Responsible party
Julie Lovegrove (Director of Hugh Sinclair Unit, University of Reading) — Principal investigator
First posted
Mar 3, 2022
Start date
Jan 13, 2020
Primary completion
Jun 30, 2021
Completion
Sep 30, 2021
Last update
Mar 3, 2022

Study contacts

Julie A Lovegrove, BSc PhD
principal investigator · University of Reading

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Coconut Oil · Plant Oils

Start the discussion